Heart Failure/Transplantation
Cardiogenic Shock | Emergency department-focused management
25 Jan, 2023 | 11:21h | UTCCardiogenic Shock: Emergency Department-Focused Management – emDocs
Related: The medical treatment of cardiogenic shock – Journal of Intensive Medicine
2023 ACC expert consensus decision pathway on comprehensive multidisciplinary care for the patient with cardiac amyloidosis
24 Jan, 2023 | 14:29h | UTCKey Points: 2023 ACC Expert Consensus on Cardiac Amyloidosis – American College of Cardiology
Commentary on Twitter
.@ACCinTouch's 🆕 Expert Consensus Decision Pathway provides practical and timely guidance on the diagnosis and management of cardiac #amyloidosis, with an emphasis on comprehensive multidisciplinary care.
Learn more: https://t.co/1SunbtuQpO#JACC #CardioOnc #CardioTwitter pic.twitter.com/DLvFUpajHC
— JACC Journals (@JACCJournals) January 23, 2023
Review | Getting ahead of the game: in-hospital initiation of HFrEF therapies
20 Jan, 2023 | 14:24h | UTC
Cohort Study | Left atrial mechanical dysfunction and risk of ischemic stroke in people without atrial fibrillation
20 Jan, 2023 | 14:23h | UTCLeft Atrial Mechanical Dysfunction and the Risk for Ischemic Stroke in People Without Prevalent Atrial Fibrillation or Stroke: A Prospective Cohort Study – Annals of Internal Medicine (link to abstract – $ for full-text)
Commentaries:
Left Atrial Dysfunction and Risk for Ischemic Stroke – American College of Cardiology
Left Atrial Dysfunction Tied to Cerebral Infarcts in Absence of Prior AF, Stroke – TCTMD
Left Atrial Reservoir Strain Plus CHA₂DS₂-VASc Ups Stroke Prediction – HealthDay
Commentary on Twitter
A study of persons without a history of #AtrialFibrillation or #stroke has found that measuring left atrial mechanical function can improve stroke prediction. https://t.co/QEYHRFDPop @Maheshwari_EP @PennStHershey pic.twitter.com/pIutPcW5Sm
— Annals of Int Med (@AnnalsofIM) December 20, 2022
RCT | No difference in survival with Torsemide vs. Furosemide after discharge of patients hospitalized with heart failure
19 Jan, 2023 | 14:26h | UTCEffect of Torsemide vs Furosemide After Discharge on All-Cause Mortality in Patients Hospitalized With Heart Failure: The TRANSFORM-HF Randomized Clinical Trial – JAMA (free for a limited period)
Editorial: TRANSFORM-HF—Can We Close the Loop on Diuretics in Heart Failure? – JAMA (free for a limited period)
News Release: Comparison of diuretics shows no difference in heart failure survival – NIH/National Heart, Lung and Blood Institute
Commentary on Twitter
Among patients discharged after hospitalization for heart failure, torsemide compared with furosemide did not result in a significant difference in all-cause mortality over 12 months. https://t.co/EwoVzRigkS pic.twitter.com/5dvhJ1oVaf
— JAMA (@JAMA_current) January 17, 2023
Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments
17 Jan, 2023 | 13:08h | UTC
Commentary on Twitter
Genetic causes of heart failure with preserved ejection fraction: emerging pharmacological treatments https://t.co/LCV8X0t4CZ @escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes pic.twitter.com/InOj7mDts7
— European Society of Cardiology Journals (@ESC_Journals) January 16, 2023
A multidisciplinary approach for the emergency care of patients with left ventricular assist devices
12 Jan, 2023 | 12:49h | UTC
Review | Predictors of early heart failure rehospitalization among older adults with preserved and reduced ejection fraction
11 Jan, 2023 | 13:58h | UTC
Cohort Study | Risk of heart failure in congenital heart disease
10 Jan, 2023 | 14:14h | UTCNews Release: Heart failure more common in heart defect survivors starting at young age – American Heart Association
The year in cardiovascular medicine 2022: the top 10 papers in heart failure and cardiomyopathies
9 Jan, 2023 | 14:10h | UTC
Commentary on Twitter
The Year in Cardiovascular Medicine 2022 series: the Top 10 papers in Heart Failure and Cardiomyopathies https://t.co/w6opcMPcBa@escardio #EHJ #ESCYoung #cardiotwitter @ehj_ed @rladeiraslopes #HeartFailure #Cardiomyopathies pic.twitter.com/UrrX2LUQdI
— European Society of Cardiology Journals (@ESC_Journals) January 2, 2023
AHA Scientific Statement | Complementary and alternative medicines in the management of heart failure.
9 Dec, 2022 | 13:40h | UTCNews Release: Some benefits, potential risks with alternative medicines for heart failure – American Heart Association
ACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison.
8 Dec, 2022 | 12:57h | UTCACC/AHA/HFSA 2022 and ESC 2021 guidelines on heart failure comparison – ESC Heart Failure
Original Guidelines:
#ACC22 – 2022 AHA/ACC/HFSA Guideline for the Management of Heart Failure.
Review | How to assess systemic venous congestion with point of care ultrasound.
6 Dec, 2022 | 13:37h | UTC
SR | Methamphetamine-associated heart failure.
5 Dec, 2022 | 00:06h | UTCMethamphetamine-associated heart failure: a systematic review of observational studies – Heart
News Release: Prevalence of ‘meth’ heart failure now in wide range of social class and racial groups – BMJ Newsroom
Commentaries: Prevalence of Methamphetamine-Related Heart Failure Increasing – HealthDay
Fluid volume homeostasis in heart failure: a tale of 2 circulations.
5 Dec, 2022 | 00:00h | UTC
M-A | Risk of hypovolemia associated with sodium–glucose cotransporter-2 inhibitors treatment.
2 Dec, 2022 | 14:31h | UTC
Epidemiology of heart failure in young adults: a French nationwide cohort study.
2 Dec, 2022 | 14:19h | UTC
M-A | Sodium restriction in patients with heart failure.
1 Dec, 2022 | 14:08h | UTCSodium Restriction in Patients With Heart Failure: A Systematic Review and Meta-Analysis of Randomized Clinical Trials – Circulation: Heart Failure (link to abstract – $ for full-text)
Commentary: Sodium Restriction No Help, No Harm in HF, Meta-analysis Confirms – TCTMD
Commentary on Twitter
In a meta-analysis of 17 RCT incl. the SODIUM-HF RCT, dietary sodium restriction did not reduce the risk of death or hospitalization in patients w/ HF @justinezekowitz @CVC_UAlberta #AHAJournals https://t.co/7xEr1bJgkz pic.twitter.com/4Gfrlx264i
— Circ: Heart Failure (@CircHF) November 17, 2022
2ry analysis of a RCT | Decongestion with acetazolamide in acute heart failure across the spectrum of left ventricular EF.
25 Nov, 2022 | 12:45h | UTCOriginal Study: RCT | Acetazolamide resulted in faster decongestion in patients with acute decompensated heart failure with volume overload.
Commentary on Twitter
#OriginalResearch simpub #AHA2022 #CIRCAHA22: Acetazolamide added to loop diuretics ⬆️ likelihood of successful decongestion similarily in patients with HFrEF, HFmrEF and HFpEF. Data from the #ADVOR trial. @PieterMartensMD @WilfriedMullens #AHAJournals https://t.co/MkISN2H1vA pic.twitter.com/qFjCKdRaF6
— Circulation (@CircAHA) November 6, 2022
RCT | Impact of empagliflozin on decongestion in acute heart failure.
23 Nov, 2022 | 14:04h | UTCCommentary: Empagliflozin in Patients Hospitalized for Acute Heart Failure – EMPULSE – American College of Cardiology
Commentary on Twitter
What's the impact of empagliflozin on decongestion in acute heart failure? New insights from the EMPULSE trial in EHJ!https://t.co/O1MZTFPWCc#SGLT2 #decongestion #heartfailure #empagliflozin #cardiotwitter @escardio @ESC_Journals pic.twitter.com/QLJYNgl1Zo
— EHJ Editor-in-Chief (@ehj_ed) October 19, 2022
Under a https://creativecommons.org/licenses/by-nc/4.0/ license
Cohort Study | Prognostic prediction of genotype vs. phenotype in genetic cardiomyopathies.
23 Nov, 2022 | 13:57h | UTC
Commentary on Twitter
We are out with our last big work on the importance of genotype for the prognostic stratification of Cardiomyopathies! @CardiologyASUGI @Trieste_Denver @JACCJournals @PaldinoAlessia https://t.co/82byVNnUhK pic.twitter.com/KYoxDXkzr6
— matteo dal ferro (@matteodalferro) November 17, 2022
Under a Creative Commons license
Right heart failure in the ED: approach to diagnosis and management.
23 Nov, 2022 | 13:54h | UTCRight Heart Failure in the ED: Approach to Diagnosis and Management – emDocs
RCT | Influenza vaccine to reduce adverse vascular events in patients with heart failure.
18 Nov, 2022 | 13:26h | UTCCommentary:
Flu vaccines cut pneumonia, cardiovascular issues in heart failure patients – CIDRAP
Flu Shot Could Be Lifesaver for Folks With Heart Failure – HealthDay
M-A | Effect of pharmacological treatment on outcomes of heart failure with preserved ejection fraction.
18 Nov, 2022 | 13:14h | UTC
RCT | Early routine use of ECMO fails to improve outcomes in patients with cardiogenic shock.
11 Nov, 2022 | 14:01h | UTCCommentaries:
Early ECMO No Better Than Watch-and-Wait Approach in Cardiogenic Shock – TCTMD
Immediate Use of ECMO Did Not Improve Outcomes in Patients with Cardiogenic Shock – HCP Live
Commentary on Twitter
#OriginalResearch simpub #AHA2022: In this #RCT immediate implementation of VA-ECMO in patients with cardiogenic shock did not improve clinical outcomes compared with an early conservative strategy which allowed downstream use of… #CIRCAHA22 #AHAJournals https://t.co/03qVyC0Vgl pic.twitter.com/WRNDsAZfpD
— Circulation (@CircAHA) November 6, 2022